Nikhil Prasad Fact checked by:Thailand Medical News Team Jul 03, 2026 1 hour, 29 minutes ago
Medical News: Natural Resin Ingredient Triggers Cancer Cell Death in Laboratory Study
Researchers in Mexico have uncovered encouraging evidence that phytochemical compounds found in Boswellia serrata, better known as Indian frankincense, may offer a new way to fight one of the world's deadliest cancers. Their latest study found that both the plant's essential oil and one of its most active natural compounds, acetyl-11-keto-β-boswellic acid (AKBA), were highly effective at destroying liver cancer cells in laboratory experiments.
.jpg)
Natural frankincense compound AKBA demonstrated remarkable ability to destroy liver cancer cells and shrink
laboratory-grown tumor models, raising hopes for future treatments
The research was conducted by scientists from the Universidad Autónoma Metropolitana–Iztapalapa, the Universidad Autónoma del Estado de Morelos, and the Centro de Investigación Biomédica del Sur of the Instituto Mexicano del Seguro Social, all in Mexico.
Targeting One of the Deadliest Cancers
Hepatocellular carcinoma is the most common form of liver cancer and remains among the leading causes of cancer deaths worldwide. Many patients are diagnosed only after the disease has already progressed, while current treatments often produce serious side effects or gradually become less effective as cancer cells develop drug resistance.
Seeking safer and more effective alternatives, the researchers turned to Boswellia serrata, a medicinal tree that has been used for centuries in traditional Ayurvedic medicine. Although the resin has long been valued for its anti-inflammatory properties, scientists wanted to determine whether its natural compounds could also directly attack liver cancer cells.
AKBA Outperformed the Essential Oil
The team tested Boswellia essential oil alongside purified AKBA using human liver cancer cells grown both in standard laboratory cultures and in three-dimensional tumor-like clusters that more closely resemble real tumors.
The results were striking. While the essential oil significantly slowed cancer cell growth, AKBA proved even more potent. After 72 hours of treatment, AKBA eliminated up to 95 percent of cancer cells at certain concentrations, demonstrating considerably greater activity than the whole essential oil.
Even more impressive, AKBA remained highly effective in three-dimensional tumor spheroids, reducing both the number and size of these miniature tumors. Because three-dimensional models behave much more like actual cancers inside the human body, these findings suggest the compound could retain its effectiveness beyond simple laboratory cell cultures.
In this
Medical News report, the findings highlight that purified AKBA may become the most promising candidate for future anti-cancer drug development from Boswellia rather than the complete essential oil itself.
Cancer Cells Were Programmed
to Self-Destruct
Instead of merely slowing cancer growth, the researchers discovered that AKBA actively triggered apoptosis, the body's natural process of eliminating damaged or dangerous cells.
The treatment dramatically increased activation of caspase-3, one of the key proteins responsible for initiating cellular self-destruction. Interestingly, the compound produced very little effect on proteins involved in controlling the cell cycle or those associated with cancer spread, suggesting that its primary action is to directly activate cancer cell death rather than simply preventing cells from multiplying.
Computer modeling also revealed another possible explanation. Several Boswellia compounds, especially longifolene and AKBA, appeared capable of interacting with an enzyme called 5-lipoxygenase (5-LO), which many cancers rely on to promote survival and inflammation. Blocking this enzyme may help switch off survival signals inside tumor cells while encouraging apoptosis.
A Promising Step Toward New Liver Cancer Treatments
Although the findings are highly encouraging, the researchers emphasize that these experiments were performed only in laboratory-grown liver cancer cells. Human clinical trials are still needed to determine whether AKBA is safe, effective, and capable of producing similar benefits in patients.
Nevertheless, the study provides compelling evidence that Boswellia-derived compounds could become valuable additions to future liver cancer therapies. AKBA appears especially attractive because it attacks cancer cells through a mechanism that differs from many existing chemotherapy drugs, potentially allowing future combination treatments that overcome drug resistance while causing fewer unwanted side effects. The encouraging results from both laboratory experiments and computer simulations provide a strong scientific foundation for advancing this natural compound into animal studies and eventually carefully designed clinical trials.
The study findings were published in the peer reviewed International Journal of Molecular Sciences.
https://www.mdpi.com/1422-0067/27/13/5978
For the latest research on liver cancer, keep on logging to Thailand
Medical News.
Read Also:
https://www.thailandmedical.news/articles/cancer
https://www.thailandmedical.news/articles/herbs-and-phytochemicals
Share
Tweet
Share
